Business Description
Omnicare Inc
ISIN : US6819041087
Description
Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | 3.87 | |||||
| Interest Coverage | 3.35 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.31 | |||||
| Beneish M-Score | -2.78 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.9 | |||||
| 3-Year EBITDA Growth Rate | 3.7 | |||||
| 3-Year EPS without NRI Growth Rate | 7.3 | |||||
| 3-Year FCF Growth Rate | -3.1 | |||||
| 3-Year Book Growth Rate | -7.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.65 | |||||
| Quick Ratio | 1.18 | |||||
| Days Inventory | 33.05 | |||||
| Days Sales Outstanding | 33.96 | |||||
| Days Payable | 20.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.84 | |||||
| Dividend Payout Ratio | 0.52 | |||||
| 3-Year Dividend Growth Rate | 75 | |||||
| 5-Year Yield-on-Cost % | 9.87 | |||||
| 3-Year Average Share Buyback Ratio | 2.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.26 | |||||
| Operating Margin % | 6.23 | |||||
| Net Margin % | 2.57 | |||||
| FCF Margin % | 7.47 | |||||
| ROE % | 6.58 | |||||
| ROA % | 2.71 | |||||
| ROIC % | 5.54 | |||||
| ROC (Joel Greenblatt) % | 33.93 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 62.43 | |||||
| Forward PE Ratio | 21.05 | |||||
| PE Ratio without NRI | 61.99 | |||||
| Shiller PE Ratio | 89.51 | |||||
| PEG Ratio | 7.95 | |||||
| PS Ratio | 1.55 | |||||
| PB Ratio | 3.72 | |||||
| Price-to-Free-Cash-Flow | 21.89 | |||||
| Price-to-Operating-Cash-Flow | 19.34 | |||||
| EV-to-EBIT | 26.6 | |||||
| EV-to-EBITDA | 20.2 | |||||
| EV-to-Revenue | 1.66 | |||||
| Price-to-Projected-FCF | 1.64 | |||||
| Price-to-Median-PS-Value | 2.42 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.97 | |||||
| Earnings Yield (Greenblatt) % | 3.79 | |||||
| Forward Rate of Return (Yacktman) % | 19.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Omnicare Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5,646.188 | ||
| EPS (TTM) (€) | 1.401 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 46.44 - 98 | ||
| Shares Outstanding (Mil) | 96.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Omnicare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Omnicare Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Omnicare Inc Frequently Asked Questions
What is Omnicare Inc(FRA:OMN)'s stock price today?
The current price of FRA:OMN is €87.40. The 52 week high of FRA:OMN is €98.00 and 52 week low is €46.44.
When is next earnings date of Omnicare Inc(FRA:OMN)?
The next earnings date of Omnicare Inc(FRA:OMN) is .
Does Omnicare Inc(FRA:OMN) pay dividends? If so, how much?
The Dividend Yield %  of Omnicare Inc(FRA:OMN) is 0.84% (As of Today), Highest Dividend Payout Ratio of Omnicare Inc(FRA:OMN) was 0.69. The lowest was 0.03. And the median was 0.09. The  Forward Dividend Yield % of Omnicare Inc(FRA:OMN) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers